MedImmune Message Board - Msg: 19512068

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MedImmune

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Arthur Radley who wrote (257)	11/17/2003 9:12:10 PM
From: tuck	Read Replies (1) of 416

Yeah, and what's really amazing to me is that folks who are bullish on IDBE's FluInsure have bid that stock up so much and given only a little back recently -- despite the fact that it takes two doses of FluInsure to achieve efficacy. Twice the sales? Not if no one even wants to pay for one. I'll bet you this starts to sink in soon, and IDBE will continue to give it back, too. Until it becomes a fairly valued bioterror stock, like, uh, VaxGen. MEDI's fortunes will now ride more heavily on AMEV's drugs. What else does MEDI have in the pipe? Not much that I can recall off of the top of my head. Go NuMax! Go Vitaxin! Cheers, Tuck (whose Mom owns AMEV, which stock has powered his '03 stock picking portfolio into the lead of late) (Congrats on Flamel!)

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next